Induction Chemotherapy Combined With Immunotherapy for Locally Advanced Hypopharyngeal Carcinoma

NCT04156698 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

51

Enrollment

OTHER

Sponsor class

Conditions

Hypopharyngeal Carcinoma
Immunotherapy
Chemotherapy

Interventions

DRUG: Docetaxel
DRUG: Cisplatin
DRUG: Capecitabine
DRUG: Camrelizumab

Sponsor

Eye & ENT Hospital of Fudan University